|
26.05.25 - 11:48
|
CEO Jonas Klarén acquires warrants in GARO (Cision)
|
|
CEO Jonas Klarén has today acquired 500,000 warrants in GARO AB (publ).
The acquisition of the warrants has been made in accordance with GARO's warrant program 2025/2028 resolved at the Annual General Meeting on May 14 and at market value calculated by independent valuation agencies. The price of the warrant has been set at SEK 3.64.
Each warrant entitles the holder to subscribe for one (1) new ordinary share in GARO in three years at a subscription price of SEK 28.85.
For more information, please contact:
Helena Claesson, CFO: +46 (0)70 676 07 50
GARO AB (...
|
|
14.05.25 - 20:01
|
Resolutions at GARO Aktiebolag′s Annual General Meeting 2025 (Cision)
|
|
The Annual General Meeting approved the presented income statements and balance sheets and remuneration report and approved discharge from liability for board members and the managing director. In addition, the following decisions were made.
Election of Board of Directors
Rickard Blomqvist, Martin Althén, Johan Paulsson and Lars Kongstad were re-elected as board members and Kristine Lindberg and Axel Barnekow Widmark were elected as new board members. Axel Barnekow Widmark was elected as Chairperson of the board.
Fees to the Board of Directors
It was resolved that...
|
|
12.05.25 - 13:36
|
Agenus Reports Q1 2025 Financial Results and Key Business Updates (Business Wire)
|
|
BOT/BAL Achieves Breakthrough Response Rates in MSS Cancers — Oral AACR Data Spotlight Pan-Tumor Neoadjuvant Success
Seasoned Leader Onboard to Accelerate BOT/BAL Toward Registration Milestones
Near-Term Capital Transaction Poised to Bolster Liquidity
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus” or the “Company”) (NASDAQ: AGEN), a leader in immuno-oncology, today reported financial and operational results for the first quarter of 2025, and shared key clinical and strategic milestones supporting the advancement of its botensilimab (BOT) and balstilimab (BAL) program.
“The growing strength of our BOT/BAL data across multiple hard-to-treat cancers reinforces our conviction in its transformative potential and fuels our unwavering commitment to delivering this combination to patients,” said Garo Armen, Ph.D., Chairman and CEO of Agenus. “With expanded datasets, key leadership appointments, and the FDA's renewed focus on accelerating cures and meaningful treatments, Agenus is enteri...
|
|
07.05.25 - 16:01
|
Presentation of the interim report January - March 2025 on May 14 (Cision)
|
|
GARO will publish its report for the first quarter 2025 at 14.00 CET on May 14
Conference call at 15.00 CET
The company will host a conference call at 15.00 CET the same day. The conference will be hosted by Jonas Klarén, President & CEO and Helena Claesson, Chief Financial Officer.
Dial in numbers:
Sweden: +46 (0)20 089 0141
International: +44 (https://www.netroadshow.com/events/global-numbers?confId=65194) (0)207 107 0613
The presentation material will be published at www.garo.se prior to the conference call. The conference will also be audio webcasted...
|
|
29.04.25 - 08:36
|
GARO strengthens Group Management and appoints new COO, CTO and CHRO (Cision)
|
|
GARO AB strengthens Group Management by appointing three key employees to the roles of Chief Operating Officer (COO), Chief Technology Officer (CTO) and Chief Human Resources Officer (CHRO). The aim is to create a stronger international business focus, and to further increase the pace of operational activities, technological development and long-term culture and competence building within the Group.
Joe Ree, Chief Operating Officer (COO)
Joe Ree has been CEO of GARO Ireland since 1989 and has contributed greatly to GARO's strong market position and growth in Ireland. Joe has...
|
|
16.04.25 - 09:01
|
GARO′s Annual Report for 2024 (Cision)
|
|
GARO´s Annual Report 2024 has been published today at the company's website.
GARO AB (publ) today announces that the company's Annual Report 2024 is now published and available at the corporate website www.garogroup.se.
The financial year covers the period from January 1 to December 31, 2024.
For more information, please contact:
Helena Claesson, CFO +46 (0)70 676 07 50
This information is such information that GARO aktiebolag is obligated to publish in accordance with the Swedish Securities Market Act. The information was published by the above mentioned...
|
|
04.04.25 - 08:00
|
Notice to the Annual General Meeting in GARO Aktiebolag (publ) (Cision)
|
|
The shareholders of GARO Aktiebolag (publ) (“GARO” or the “Company”), Reg. No. 556051-7772, are hereby invited to attend the Annual General Meeting (the “AGM”) to be held at 5 p.m. CEST on 14 May 2025 at the Company's premises on Järnvägsgatan 35 in Hillerstorp, Sweden. Registration will commence at 4 p.m. CEST.
A. RIGHT TO PARTICIPATE IN THE AGM
A person who wishes to participate in the AGM must:
firstly, be listed as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB concerning the circumstances on 6 May 2025, and...
|
|
11.03.25 - 12:36
|
Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program (Business Wire)
|
|
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company advancing innovative cancer therapies, today reported financial and operational results for Q4 and full-year 2024, highlighting strategic measures to substantially reduce operational costs while preserving and enhancing the potential of its leading BOT/BAL program.
"In line with our strategic objectives, we significantly reduced our annualized operational burn rate. We anticipate further reducing our annual burn to an annualized rate of approximately $50 million by mid-2025 through the externalization of development costs associated with BOT/BAL, monetization of our CMC assets, and other reductions in operating expenses," stated Garo Armen, Ph.D., Chairman and CEO of Agenus. "These steps reflect our commitment to prioritizing resources for BOT/BAL— our most promising clinical asset— while maintaining its development trajectory."
Key Operational Highlights:
A...
|
|
04.12.24 - 10:01
|
Eichrecht approval for GARO Entity Pro and the production in Poland (Cision)
|
|
The wallboxes in the GARO Entity series have previously undergone third-party certification, meaning that they have been tested and approved in accordance with the international electric vehicle conductive charging system standard (IEC61851). GARO Entity Pro has now also been approved under the German “Eichrecht” calibration law, which means that the wallbox is ready to be sold in the German market for semi-public and public charging. We have also certified our factory in Poland in accordance with the Eichrecht requirements for production, calibration and internal inspections. With its...
|
|
28.11.24 - 10:19
|
Jonas Klarén takes over as President and CEO of GARO as of January 13th, 2025 (Cision)
|
|
GARO has previously announced that Jonas Klarén has been appointed as its new President and CEO. Jonas's starting date is set for January 13, 2025
For more information, please contact:
Rickard Blomqvist, Chairman +46 70 537 52 87
The information was published by the abovementioned contact person on November 28, 2024, at 10.15 a.m. CET....
|
|
15.11.24 - 08:18
|
GARO recruits Jonas Klarén as new President and CEO (Cision)
|
|
GARO has recruited Jonas Klarén as its new President and CEO. Jonas Klarén's most recent position was as CEO of Infratek Sverige AB, which is part of the French VINCI Group, listed on the Paris Stock Exchange.
Jonas has extensive experience from the energy and power supply industry and has successfully developed Infratek within VINCI Energies. He also worked at ABB earlier in his career and he holds an M.Sc. in Electric Engineering from Chalmers University of Technology in Gothenburg. Jonas will assume his position as President and CEO as soon as possible, but in six months at the latest....
|
|
07.11.24 - 08:31
|
Presentation of the interim report January - September 2024 on November 15 (Cision)
|
|
GARO will publish its report for the third quarter 2024 at 08.30 CET on November 15.
Conference call at 9.30 CET
The company will host a conference call at 9.30 CET the same day. The conference will be hosted by Patrik Andersson, President & CEO and Helena Claesson, Chief Financial Officer.
Dial in numbers:
Sweden: +46 (0)20 089 0141
International: +44 (0)207 107 06 13
The presentation material will be published at www.garo.se prior to the conference call. The conference will also be audio webcasted in “listen-only” mode at the GARO website www.garo....
|
|
14.10.24 - 11:02
|
Nomination Committee appointed ahead of the 2025 Annual General Meeting (Cision)
|
|
In accordance with the guidelines adopted by the Annual General Meeting on May 4, 2017, GARO has established a Nomination Committee. The Nomination Committee is to prepare and make proposals to the 2025 Annual General Meeting concerning:
· the Chairman of the Annual General Meeting;
· candidates for the post of Chairman and other members of the Board;
· election and remuneration of the company's auditors;
· Board fees and distribution between the Chairman and other members as well as remuneration for committee work; and
· any changes to the instructions for the Nomination...
|
|
|
25.09.24 - 08:31
|
GARO launches new electric vehicle wallbox – specially adapted for homes (Cision)
|
|
Today, GARO can present the GARO Entity Home wallbox – a new wallbox based on the GARO Entity technology platform and developed especially for connected homes. Combining advanced technology with ease of use, this new product offers a new, safe, cost-effective and reliable charging solution for consumers wanting to charge their electric vehicles at home.
GARO Entity Home has a compact and stylish design that blends seamlessly with home environments and is equipped with smart functions to optimise the charging process. The GARO Connect app enables you to manage, control and monitor the...
|
|
|
16.08.24 - 08:31
|
Interim report January – June 2024 (Cision)
|
|
GARO Electrification reports a stable quarter while GARO E-mobility continues to face challenging market conditions
APRIL – JUNE 2024
· Net sales amounted to MSEK 306.3 (386.0).
· Net sales declined 21% (+10).
· EBIT amounted to MSEK -4.3 (18.2).
· EBIT margin amounted to -1.4% (4.7).
· Net income was MSEK -8.9 (20.1).
· Loss per share amounted to SEK -0.18 (earnings: 0.40).
JANUARY – JUNE 2024
· Net sales amounted to MSEK 598.8 (756.3).
· Net sales declined 21% (+3).
· EBIT amounted to MSEK -10.9 (45.9).
· EBIT margin amounted to -1.8% (6.1).
·...
|
|
16.08.24 - 08:19
|
GARO starts recruitment of a new CEO. Patrik Andersson will remain CEO until his replacement takes up the position (Cision)
|
|
The recruitment of a new CEO has started and the aim is to announce the appointment of a successor during the autumn, with an expected start in the first quarter of 2025.
Under Patrik Andersson's leadership, GARO has completed several strategic initiatives, such as organizing operations into two business areas (GARO Electrification and GARO E-mobility), developing the new product platform GARO Entity, and investing in production and delivery capacity. Going forward, GARO will be entering an increasingly international and growth-oriented phase in order to capitalize on investments made....
|
|
09.08.24 - 08:31
|
Presentation of the interim report January - June 2024 on August 16 (Cision)
|
|
GARO will publish its report for the second quarter 2024 at 08.30 CET on August 16.
Conference call at 9.30 CET
The company will host a conference call at 9.30 CET the same day. The conference will be hosted by Patrik Andersson, President & CEO and Helena Claesson, Chief Financial Officer.
Dial in numbers:
Sweden: +46 (0)20 089 0141
International: +44 (0)207 107 0613
ID number (access code): 43 72 94 46
The presentation material will be published at www.garo.se prior to the conference call. The...
|
|